CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-26 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +3,125 | 9,348 | ||
| 2023-07-26 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −930 | $17.64 | $16K | 8,418 |
| 2023-07-26 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,125 | 6,250 | ||
| 2023-06-21 | Mathers Edward T Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | Mathers Edward T Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | TETRAULT LYNN A. Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | TETRAULT LYNN A. Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | MCGIRR DAVID W J Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | MCGIRR DAVID W J Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | JEAN CHRISTOPHE Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | JEAN CHRISTOPHE Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | GOOD JENNIFER L Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | GOOD JENNIFER L Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | Bedrosian Camille L Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | Bedrosian Camille L Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-21 | Arbuckle Stuart A Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2023-06-21 | Arbuckle Stuart A Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-06-16 | Smith Hunter C Chief Financial Officer | Option exercise | +2,000 | $6.88 | $14K | 61,406 |
| 2023-06-16 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (right to buy) | −2,000 | 161,094 | ||
| 2023-04-14 | Mazabraud Yann EVP, Head of International | Returned to the company · Restricted Stock Units | −41,500 | 0 |
Page 34 of 36 · 701 trades